Role of Nano Enzyme in Diagnosis, Prognosis and Treatment of Gastrointestinal Tract (GIT) Cancer
Nano Enzymes in Diagnosis, Prognosis, and Treatment of GIT Cancer
DOI:
https://doi.org/10.69750/dmls.01.01.015Keywords:
Gastrointestinal tract cancer, Nano-enzymes, Diagnosis, prognosis, treatment, Drug delivery, Biosensors, Targeted therapy, Imaging, Biomarkers.Abstract
Background:The most common life-threatening problem in population is gastrointestinal tract (GIT) cancer and its mortality rate is very high. Now a days Nanotechnology is a modern way of diagnosis and treatment. Nano-enzymes showed best diagnosis efficacy of treatment and disease progression
Aims and objectives: The aims and objectives of current review were a comprehensive overview of Nano-enzymes in the diagnosis, prognosis, and treatment of gastrointestinal tract cancer.
Practical Implications:Through Nano-enzymes different types of cancer may be diagnosis, prognosis, and treated. While the treatment of gastrointestinal tract cancer with Nano-enzymes showed best results. In this review, we outlined the many types of nanoparticles used to treat esophageal cancer.
Conclusion:A common gastrointestinal cancer with a poor prognosis and a high fatality rate is esophageal cancer. Despite the development of multiple therapy approaches, patients with esophageal cancer still have a low 5-year survival rate. Traditional methods of delivering anti-cancer medications have some drawbacks, including no targeted administration and general toxicity. For the treatment of Esophageal cancer, nanoparticles offer a viable platform for drug delivery since they have a number of outstanding benefits, including less side effects, a longer circulation duration, and a preference for accumulating at the tumor site. These include polymers, micelles, liposomes, inorganic nanoparticles, and organic nanoparticles. In this review, we outlined the many types of nanoparticles used to treat esophageal cancer.
Downloads
References
Amin A, Amin H. Lipoprotein nanoparticles in diagnosis and treatment of cancer. MOJ Drug Des Develop Ther. 2018;2(1):15-8.
Hussain Z, Khan JA, Murtaza S. Nanotechnology: An emerging therapeutic option for breast cancer. Critical Reviews™ in Eukaryotic Gene Expression. 2018;28(2).
Rajana N, Mounika A, Chary PS, Bhavana V, Urati A, Khatri D, et al. Multifunctional hybrid nanoparticles in diagnosis and therapy of breast cancer. Journal of Controlled Release. 2022;352:1024-47.
Singh RS, Singh T, Singh AK. Enzymes as diagnostic tools. Advances in enzyme technology: Elsevier; 2019. p. 225-71.
Abdolmaleki A, Asadi A, Gurushankar K, Shayan TK, Sarvestani FA. Importance of nano medicine and new drug therapies for cancer. Advanced Pharmaceutical Bulletin. 2021;11(3):450.
Vimal A, Kumar A. Transforming the healthcare system through therapeutic enzymes. Enzymes in Food Biotechnology: Elsevier; 2019. p. 603-25.
Hosseini SM, Okoye I, Chaleshtari MG, Hazhirkarzar B, Mohamadnejad J, Azizi G, et al. E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions. Clinica Chimica Acta. 2019;498:126-34.
Cao F, Jin L, Gao Y, Ding Y, Wen H, Qian Z, et al. Artificial-enzymes-armed Bifidobacterium longum probiotics for alleviating intestinal inflammation and microbiota dysbiosis. Nature Nanotechnology. 2023:1-11.
Naeem M, Awan UA, Subhan F, Cao J, Hlaing SP, Lee J, et al. Advances in colon-targeted nano-drug delivery systems: challenges and solutions. Archives of pharmacal research. 2020;43:153-69.
Gupta S, Jain A, Chakraborty M, Sahni JK, Ali J, Dang S. Oral delivery of therapeutic proteins and peptides: a review on recent developments. Drug delivery. 2013;20(6):237-46.
Chivere VT, Kondiah PP, Choonara YE, Pillay V. Nanotechnology-based biopolymeric oral delivery platforms for advanced cancer treatment. Cancers. 2020;12(2):522.
Herszényi L, Barabás L, Hritz I, István G, Tulassay Z. Impact of proteolytic enzymes in colorectal cancer development and progression. World journal of gastroenterology: WJG. 2014;20(37):13246.
Aggarwal V, Tuli HS, Tania M, Srivastava S, Ritzer EE, Pandey A, et al., editors. Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement. Seminars in cancer biology; 2022: Elsevier.
Couvreur P, Vauthier C. Nanotechnology: intelligent design to treat complex disease. Pharmaceutical research. 2006;23:1417-50.
Wang J, Dong R, Wu H, Cai Y, Ren B. A review on artificial micro/nanomotors for cancer-targeted delivery, diagnosis, and therapy. Nano-Micro Letters. 2020;12:1-19.
Sadighbayan D, Sadighbayan K, Tohid-Kia MR, Khosroushahi AY, Hasanzadeh M. Development of electrochemical biosensors for tumor marker determination towards cancer diagnosis: Recent progress. TrAC Trends in Analytical Chemistry. 2019;118:73-88.
Yang M, Yang F, Chen W, Liu S, Qiu L, Chen J. Bacteria-mediated cancer therapies: opportunities and challenges. Biomaterials Science. 2021;9(17):5732-44.
Baig MH, Adil M, Khan R, Dhadi S, Ahmad K, Rabbani G, et al., editors. Enzyme targeting strategies for prevention and treatment of cancer: Implications for cancer therapy. Seminars in cancer biology; 2019: Elsevier.
Brakmane G, Winslet M, Seifalian A. Systematic review: the applications of nanotechnology in gastroenterology. Alimentary pharmacology & therapeutics. 2012;36(3):213-21.
Hua S, Marks E, Schneider JJ, Keely S. Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue. Nanomedicine: nanotechnology, biology and medicine. 2015;11(5):1117-32.
Mahomoodally M, Aumeeruddy M, Rengasamy KR, Roshan S, Hammad S, Pandohee J, et al., editors. Ginger and its active compounds in cancer therapy: From folk uses to nano-therapeutic applications. Seminars in cancer biology; 2021: Elsevier.
Potter C, Harris A. Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer. British journal of cancer. 2003;89(1):2-7.
Wang K, Shen R, Meng T, Hu F, Yuan H. Nano-drug delivery systems based on different targeting mechanisms in the targeted therapy of colorectal cancer. Molecules. 2022;27(9):2981.
Nikolopoulos D, Theocharis S, Kouraklis G. Ghrelin's role on gastrointestinal tract cancer. Surgical oncology. 2010;19(1):e2-e10.
Pope D, Ramesh H, Gennari R, Corsini G, Maffezzini M, Hoekstra H, et al. Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surgical oncology. 2006;15(4):189-97.
Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract. A study of 117 cases presenting with gastrointestinal disease. Cancer. 1978;42(2):693-707.
Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. The Lancet. 2020;396(10251):635-48.
Herszényi L, István G, Cardin R, De Paoli M, Plebani M, Tulassay Z, et al. Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers. European Journal of Cancer Prevention. 2008:438-45.
Guleria K, Singh HP, Kaur H, Sambyal V. ABO blood groups in gastrointestinal tract (GIT) and breast carcinoma patients. The Anthropologist. 2005;7(3):189-92.
Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. Challenges in liver cancer and possible treatment approaches. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer. 2020;1873(1):188314.
Cao Y, Nishihara R, Wu K, Wang M, Ogino S, Willett WC, et al. Population-wide impact of long-term use of aspirin and the risk for cancer. JAMA oncology. 2016;2(6):762-9.
Jackson TC, Patani BO, Ekpa DE. Nanotechnology in diagnosis: a review. Advances in Nanoparticles. 2017;6(3):93-102.
Feng Z, Meng H. Efficient nano-enabled therapy for gastrointestinal cancer using silicasome delivery technology. Science China Chemistry. 2021;64:1946-57.
Tinkle S, McNeil SE, Mühlebach S, Bawa R, Borchard G, Barenholz Y, et al. Nanomedicines: addressing the scientific and regulatory gap. Annals of the New York Academy of Sciences. 2014;1313(1):35-56.
Obaid G, Broekgaarden M, Bulin A-L, Huang H-C, Kuriakose J, Liu J, et al. Photonanomedicine: a convergence of photodynamic therapy and nanotechnology. Nanoscale. 2016;8(25):12471-503.
Pelaz B, Alexiou C, Alvarez-Puebla RA, Alves F, Andrews AM, Ashraf S, et al. Diverse applications of nanomedicine. ACS nano. 2017;11(3):2313-81.
Sarkar S, Sarkar SC. Chapter-4 application of nanotechnology in medicine. MED CAL SCIENCES. 2019;117:49.
Mukherjee S, Patra CR. Therapeutic application of anti-angiogenic nanomaterials in cancers. Nanoscale. 2016;8(25):12444-70.
Zhang T, Zhu G, Lu B, Peng Q. Oral nano-delivery systems for colon targeting therapy. Pharmaceutical nanotechnology. 2017;5(2):83-94.
Ell C, Remke S, May A, Helou L, Henrich R, Mayer G. The first prospective controlled trial comparing wireless capsule endoscopy with push enteroscopy in chronic gastrointestinal bleeding. Endoscopy. 2002;34(09):685-9.
Wanebo HJ, Kennedy B, Chmiel J, Steele Jr G, Winchester D, Osteen R. Cancer of the stomach. A patient care study by the American College of Surgeons. Annals of surgery. 1993;218(5):583.
Hause RJ, Pritchard CC, Shendure J, Salipante SJ. Classification and characterization of microsatellite instability across 18 cancer types. Nature medicine. 2016;22(11):1342-50.
Ali ES, Sharker SM, Islam MT, Khan IN, Shaw S, Rahman MA, et al., editors. Targeting cancer cells with nanotherapeutics and nanodiagnostics: Current status and future perspectives. Seminars in cancer biology; 2021: Elsevier.
Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. The American journal of gastroenterology. 2015;110(2):223.
Karimi M, Ghasemi A, Zangabad PS, Rahighi R, Basri SMM, Mirshekari H, et al. Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chemical Society Reviews. 2016;45(5):1457-501.
Mallakpour S, Hussain CM, Krishna Bayineni V, Naira VR, Kadeppagari R-K. Biomedical Applications of Nanozymes: Disease Diagnosis and Therapy. Handbook of Consumer Nanoproducts. 2021:1-13.
Krishna Bayineni V, Naira VR, Kadeppagari R-K. Biomedical Applications of Nanozymes: Disease Diagnosis and Therapy. Handbook of Consumer Nanoproducts: Springer; 2022. p. 675-87.
Su Z, Du T, Liang X, Wang X, Zhao L, Wang J, et al. Nanozymes for foodborne microbial contaminants detection: Mechanisms, recent advances, and challenges. Food Control. 2022:109165.
Niu X, Cheng N, Ruan X, Du D, Lin Y. Nanozyme-based immunosensors and immunoassays: recent developments and future trends. Journal of The Electrochemical Society. 2020;167(3):037508.
Wang P, Wang T, Hong J, Yan X, Liang M. Nanozymes: a new disease imaging strategy. Frontiers in Bioengineering and Biotechnology. 2020;8:15.
Thorn CR, Howell PL, Wozniak DJ, Prestidge CA, Thomas N. Enhancing the therapeutic use of biofilm-dispersing enzymes with smart drug delivery systems. Advanced Drug Delivery Reviews. 2021;179:113916.
Munir S, Shah AA, Rahman H, Bilal M, Rajoka MSR, Khan AA, et al. Nanozymes for medical biotechnology and its potential applications in biosensing and nanotherapeutics. Biotechnology letters. 2020;42:357-73.
Xie B, Yang X, Zhang R, Guo J, Chen Z, He Y. Hollow and porous Fe3C-NC nanoballoons nanozymes for cancer cell H2O2 detection. Sensors and Actuators B: Chemical. 2021;347:130597.
Prados J, Melguizo C, Perazzoli G, Cabeza L, Carrasco E, Oliver J, et al. Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: review of recent patents. Recent patents on anti-cancer drug discovery. 2014;9(1):21-34.
Chadar R, Kesharwani P. Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer. International Journal of Pharmaceutics. 2021;605:120835.
Banerjee A, Pathak S, Subramanium VD, Dharanivasan G, Murugesan R, Verma RS. Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives. Drug discovery today. 2017;22(8):1224-32.
Laroui H, Rakhya P, Xiao B, Viennois E, Merlin D. Nanotechnology in diagnostics and therapeutics for gastrointestinal disorders. Digestive and Liver Disease. 2013;45(12):995-1002.
Bhatnagar P, Patnaik S, Srivastava AK, Mudiam MK, Shukla Y, Panda AK, et al. Anti-cancer activity of bromelain nanoparticles by oral administration. Journal of biomedical nanotechnology. 2014;10(12):3558-75.
Rath G, Goyal AK. Introduction to Nanotechnology.
Liang M, Li L-D, Li L, Li S. Nanotechnology in diagnosis and therapy of gastrointestinal cancer. World Journal of Clinical Cases. 2022;10(16):5146.
Poellmann MJ, Bu J, Liu S, Wang AZ, Seyedin SN, Chandrasekharan C, et al. Nanotechnology and machine learning enable circulating tumor cells as a reliable biomarker for radiotherapy responses of gastrointestinal cancer patients. Biosensors and Bioelectronics. 2023;226:115117.
Sun B, Fang Y, Li Z, Chen Z, Xiang J. Advances in the application of nanotechnology in the diagnosis and treatment of gastrointestinal tumors. Molecular and clinical oncology. 2015;3(2):274-80.
Sakamoto JH, van de Ven AL, Godin B, Blanco E, Serda RE, Grattoni A, et al. Enabling individualized therapy through nanotechnology. Pharmacological research. 2010;62(2):57-89.
Ringel VM, Allen IC. The Role of Nanotechnology in Detection and Treatment in Gastrointestinal Cancers. Elucidating the Role of Pattern Recognition Receptors in Understanding, Treating, and Targeting Cancer. 2019:183.
Surendiran A, Sandhiya S, Pradhan S, Adithan C. Novel applications of nanotechnology in medicine. Indian Journal of Medical Research. 2009;130(6):689-701.
Sykes PD, Neoptolemos JP, Costello E, Halloran CM. Nanotechnology advances in upper gastrointestinal, liver and pancreatic cancer. Expert Review of Gastroenterology & Hepatology. 2012;6(3):343-56.
Bollschweiler E, Boettcher K, Hoelscher AH, Siewert JR, Sasako M, Kinoshita T, et al. Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer. 1993;71(10):2918-25.
Siewert JR, Böttcher K, Stein HJ, Roder JD. Relevant prognostic factors in gastric cancer: ten-year results of the German Gastric Cancer Study. Annals of surgery. 1998;228(4):449.
Allum W, Powell D, McConkey C, Fielding J. Gastric cancer: a 25‐year review. British journal of surgery. 1989;76(6):535-40.
Meyer H-J, Wilke H. Treatment strategies in gastric cancer. Deutsches Ärzteblatt International. 2011;108(41):698.
Song Z, Wu Y, Yang J, Yang D, Fang X. Progress in the treatment of advanced gastric cancer. Tumor Biology. 2017;39(7):1010428317714626.
Layke JC, Lopez PP. Gastric cancer: diagnosis and treatment options. American family physician. 2004;69(5):1133-41.
Dassen A, Lemmens V, Van De Poll-Franse L, Creemers G-J, Brenninkmeijer S, Lips D, et al. Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. European Journal of Cancer. 2010;46(6):1101-10.
Siewert J, Böttcher K, Roder J, Busch R, Hermanek P, Meyer H. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. British Journal of Surgery. 1993;80(8):1015-8.
Kumar B, Murali A, Bharath A, Giri S. Guar gum modified upconversion nanocomposites for colorectal cancer treatment through enzyme-responsive drug release and NIR-triggered photodynamic therapy. Nanotechnology. 2019;30(31):315102.
Shanmugam H, Rengarajan C, Nataraj S, Sharma A. Interactions of plant food bioactives‐loaded nano delivery systems at the nano‐bio interface and its pharmacokinetics: An overview. Food Frontiers. 2022;3(2):256-75.
Zhang T, Zhu G, Lu B, Qian Z, Peng Q. Protein corona formed in the gastrointestinal tract and its impacts on oral delivery of nanoparticles. Medicinal Research Reviews. 2021;41(3):1835-50.
Deng S, Gu J, Jiang Z, Cao Y, Mao F, Xue Y, et al. Application of nanotechnology in the early diagnosis and comprehensive treatment of gastrointestinal cancer. Journal of Nanobiotechnology. 2022;20(1):415.
Lou X, Chen Z, He Z, Sun M, Sun J. Bacteria-mediated synergistic cancer therapy: small microbiome has a big hope. Nano-Micro Letters. 2021;13:1-26.
Mei L, Zhang Z, Zhao L, Huang L, Yang X-L, Tang J, et al. Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Advanced drug delivery reviews. 2013;65(6):880-90.
Tan YY, Yap PK, Lim GLX, Mehta M, Chan Y, Ng SW, et al. Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics. Chemico-biological interactions. 2020;329:109221.
Rahman MM, Islam MR, Akash S, Harun-Or-Rashid M, Ray TK, Rahaman MS, et al. Recent advancements of nanoparticles application in cancer and neurodegenerative disorders: At a glance. Biomedicine & Pharmacotherapy. 2022;153:113305.
Liu Y, Ding X, Li J, Luo Z, Hu Y, Liu J, et al. Enzyme responsive drug delivery system based on mesoporous silica nanoparticles for tumor therapy in vivo. Nanotechnology. 2015;26(14):145102.
Nurunnabi M, Revuri V, Huh KM, Lee Y-k. Polysaccharide based nano/microformulation: An effective and versatile oral drug delivery system. Nanostructures for oral medicine: Elsevier; 2017. p. 409-33.
Liu W, Dong Z, Liu K, Lu Y, Wu W, Qi J, et al. Targeting strategies of oral nano-delivery systems for treating inflammatory bowel disease. International Journal of Pharmaceutics. 2021;600:120461.
Vieira IRS, Conte-Junior CA. Nano-delivery systems for food bioactive compounds in cancer: Prevention, therapy, and clinical applications. Critical Reviews in Food Science and Nutrition. 2022:1-26.
Barani M, Rahdar A, Sargazi S, Amiri MS, Sharma PK, Bhalla N. Nanotechnology for inflammatory bowel disease management: Detection, imaging and treatment. Sensing and bio-sensing research. 2021;32:100417.
Fan J-X, Li Z-H, Liu X-H, Zheng D-W, Chen Y, Zhang X-Z. Bacteria-mediated tumor therapy utilizing photothermally-controlled TNF-α expression via oral administration. Nano letters. 2018;18(4):2373-80.
Alam MAU, Khatun M, Alam MAU. Recent Trend of Nanotechnology Applications to Improve Bio-accessibility of Lycopene by Nanocarrier: A Review. arXiv preprint arXiv:230110397. 2023.
He H, Du L, Xue H, An Y, Zeng K, Huang H, et al. Triple Tumor Microenvironment‐Responsive Ferroptosis Pathways Induced by Manganese‐Based Imageable Nanoenzymes for Enhanced Breast Cancer Theranostics. Small Methods. 2023:2300230.
Li W, Liu D, Zhang H, Correia A, Mäkilä E, Salonen J, et al. Microfluidic assembly of a nano-in-micro dual drug delivery platform composed of halloysite nanotubes and a pH-responsive polymer for colon cancer therapy. Acta biomaterialia. 2017;48:238-46.
Xu C, Ban Q, Wang W, Hou J, Jiang Z. Novel nano-encapsulated probiotic agents: Encapsulate materials, delivery, and encapsulation systems. Journal of Controlled Release. 2022;349:184-205.
Satapathy S, Patro CS. Solid lipid nanoparticles for efficient oral delivery of tyrosine kinase inhibitors: A nano targeted cancer drug delivery. Advanced Pharmaceutical Bulletin. 2021;12(2):298-308.
Khan H, Ullah H, Martorell M, Valdes SE, Belwal T, Tejada S, et al., editors. Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects. Seminars in cancer biology; 2021: Elsevier.
Huang J, Shu Q, Wang L, Wu H, Wang AY, Mao H. Layer-by-layer assembled milk protein coated magnetic nanoparticle enabled oral drug delivery with high stability in stomach and enzyme-responsive release in small intestine. Biomaterials. 2015;39:105-13.
Choi H, Cho SH, Hahn SK. Urease-powered polydopamine nanomotors for intravesical therapy of bladder diseases. ACS nano. 2020;14(6):6683-92.
Zhang J, Chen Z, Kankala RK, Wang S-B, Chen A-Z. Self-propelling micro-/nano-motors: Mechanisms, applications, and challenges in drug delivery. International Journal of Pharmaceutics. 2021;596:120275.
Kumar B, Kulanthaivel S, Mondal A, Mishra S, Banerjee B, Bhaumik A, et al. Mesoporous silica nanoparticle based enzyme responsive system for colon specific drug delivery through guar gum capping. Colloids and Surfaces B: Biointerfaces. 2017;150:352-61.
Ma X, Feng H, Liang C, Liu X, Zeng F, Wang Y. Mesoporous silica as micro/nano-carrier: From passive to active cargo delivery, a mini review. Journal of materials science & technology. 2017;33(10):1067-74.
Reis CP, Neufeld RJ, Ribeiro AJ, Veiga F. Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems. Nanomedicine: Nanotechnology, Biology and Medicine. 2006;2(2):53-65.
Zhang S, Langer R, Traverso G. Nanoparticulate drug delivery systems targeting inflammation for treatment of inflammatory bowel disease. Nano Today. 2017;16:82-96.
Emeje MO, Obidike IC, Akpabio EI, Ofoefule SI. Nanotechnology in drug delivery. Recent advances in novel drug carrier systems. 2012;1(4):69-106.
Lu Y, Luo Q, Jia X, Tam JP, Yang H, Shen Y, et al. Multidisciplinary strategies to enhance therapeutic effects of flavonoids from Epimedii Folium: Integration of herbal medicine, enzyme engineering, and nanotechnology. Journal of Pharmaceutical Analysis. 2022.
Song Q, Jia J, Niu X, Zheng C, Zhao H, Sun L, et al. An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy. Nanoscale. 2019;11(34):15958-70.
Shah BM, Palakurthi SS, Khare T, Khare S, Palakurthi S. Natural proteins and polysaccharides in the development of micro/nano delivery systems for the treatment of inflammatory bowel disease. International journal of biological macromolecules. 2020;165:722-37.
Meng X, Li D, Chen L, He H, Wang Q, Hong C, et al. High-performance self-cascade pyrite nanozymes for apoptosis–ferroptosis synergistic tumor therapy. ACS nano. 2021;15(3):5735-51.
Salapa J, Bushman A, Lowe K, Irudayaraj J. Nano drug delivery systems in upper gastrointestinal cancer therapy. Nano Convergence. 2020;7(1):1-17.
Singh AV, Ansari MHD, Laux P, Luch A. Micro-nanorobots: important considerations when developing novel drug delivery platforms. Expert opinion on drug delivery. 2019;16(11):1259-75.
Cafarelli A, Marino A, Vannozzi L, Puigmartí-Luis J, Pané S, Ciofani G, et al. Piezoelectric nanomaterials activated by ultrasound: the pathway from discovery to future clinical adoption. ACS nano. 2021;15(7):11066-86.
Yetisen AK, Akram MS, Lowe CR. based microfluidic point-of-care diagnostic devices. Lab on a Chip. 2013;13(12):2210-51.
Ferrari AC, Bonaccorso F, Fal'Ko V, Novoselov KS, Roche S, Bøggild P, et al. Science and technology roadmap for graphene, related two-dimensional crystals, and hybrid systems. Nanoscale. 2015;7(11):4598-810.
Nair M, Jayant RD, Kaushik A, Sagar V. Getting into the brain: potential of nanotechnology in the management of NeuroAIDS. Advanced drug delivery reviews. 2016;103:202-17.
Schuemann J, Bagley AF, Berbeco R, Bromma K, Butterworth KT, Byrne HL, et al. Roadmap for metal nanoparticles in radiation therapy: Current status, translational challenges, and future directions. Physics in Medicine & Biology. 2020;65(21):21RM02.
Lou-Franco J, Das B, Elliott C, Cao C. Gold nanozymes: from concept to biomedical applications. Nano-Micro Letters. 2021;13:1-36.
Su L, Qin S, Xie Z, Wang L, Khan K, Tareen AK, et al. Multi-enzyme activity nanozymes for biosensing and disease treatment. Coordination Chemistry Reviews. 2022;473:214784.
Chen L, Huang Q, Zhao T, Sui L, Wang S, Xiao Z, et al. Nanotherapies for sepsis by regulating inflammatory signals and reactive oxygen and nitrogen species: New insight for treating COVID-19. Redox biology. 2021;45:102046.
Sheng J, Wu Y, Ding H, Feng K, Shen Y, Zhang Y, et al. Multienzyme‐like Nanozymes: Regulation, Rational Design, and Application. Advanced Materials. 2023:2211210.
Mou X, Wu Q, Zhang Z, Liu Y, Zhang J, Zhang C, et al. Nanozymes for regenerative medicine. Small methods. 2022;6(11):2200997.
Liu D, Ju C, Han C, Shi R, Chen X, Duan D, et al. Nanozyme chemiluminescence paper test for rapid and sensitive detection of SARS-CoV-2 antigen. Biosensors and Bioelectronics. 2021;173:112817.
Kaya SI, Ozcelikay G, Mollarasouli F, Bakirhan NK, Ozkan SA. Recent achievements and challenges on nanomaterial based electrochemical biosensors for the detection of colon and lung cancer biomarkers. Sensors and Actuators B: Chemical. 2022;351:130856.
Bohunicky B, Mousa SA. Biosensors: the new wave in cancer diagnosis. Nanotechnology, science and applications. 2010:1-10.
Didamson OC, Abrahamse H. Targeted photodynamic diagnosis and therapy for esophageal cancer: Potential role of functionalized nanomedicine. Pharmaceutics. 2021;13(11):1943.
PlumX Metrics
Published
Issue
Section
License
Copyright (c) 2024 DEVELOPMENTAL MEDICO-LIFE-SCIENCES
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/public domain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
